[go: up one dir, main page]

Wu et al., 2025 - Google Patents

Glutathione‐Responsive Fluorinated Nanogels Enabling Dual‐Modal Imaging and Photodynamic Therapy

Wu et al., 2025

Document ID
9610528683161619606
Author
Wu Z
Huo S
Liang X
Wang K
Peng D
Wu D
Cao Z
Publication year
Publication venue
Advanced Healthcare Materials

External Links

Snippet

Abstract 19F magnetic resonance imaging (19F MRI) is an emerging non‐invasive imaging modality with a high signal‐to‐noise ratio (SNR) and negligible background interference from biological tissues. However, the hydrophobic nature of fluorine atoms limits both 19F …
Continue reading at advanced.onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Similar Documents

Publication Publication Date Title
Hu et al. Perfluorocarbon‐loaded and redox‐activatable photosensitizing agent with oxygen supply for enhancement of fluorescence/photoacoustic imaging guided tumor photodynamic therapy
Tao et al. Covalent organic polymers based on fluorinated porphyrin as oxygen nanoshuttles for tumor hypoxia relief and enhanced photodynamic therapy
Liu et al. Near‐infrared II light‐triggered robust carbon radical generation for combined photothermal and thermodynamic therapy of hypoxic tumors
Liu et al. HOCl‐activated aggregation of gold nanoparticles for multimodality therapy of tumors
An et al. Smart magnetic and fluorogenic photosensitizer nanoassemblies enable redox‐driven disassembly for photodynamic therapy
Zhang et al. Metal–organic framework nanoshuttle for synergistic photodynamic and low‐temperature photothermal therapy
Zhang et al. Multi‐Bioinspired MOF Delivery Systems From Microfluidics for Tumor Multimodal Therapy
Wang et al. Intracellularly acid-switchable multifunctional micelles for combinational photo/chemotherapy of the drug-resistant tumor
Duan et al. Biomimetic nanocomposites cloaked with bioorthogonally labeled glioblastoma cell membrane for targeted multimodal imaging of brain tumors
Gao et al. Hybrid graphene/Au activatable theranostic agent for multimodalities imaging guided enhanced photothermal therapy
Qi et al. Enzyme‐Mediated Intracellular Polymerization of AIEgens for Light‐Up Tumor Localization and Theranostics
Gong et al. Engineering of multifunctional nano‐micelles for combined photothermal and photodynamic therapy under the guidance of multimodal imaging
Ma et al. Host–guest polypyrrole nanocomplex for three‐stimuli‐responsive drug delivery and imaging‐guided chemo‐photothermal synergetic therapy of refractory thyroid cancer
Wu et al. RETRACTED: A Tumor Microenvironment‐Responsive Biodegradable Mesoporous Nanosystem for Anti‐Inflammation and Cancer Theranostics
Fan et al. Design of tumor acidity-responsive sheddable nanoparticles for fluorescence/magnetic resonance imaging-guided photodynamic therapy
Li et al. Developing hypoxia‐sensitive system via designing tumor‐targeted fullerene‐based photosensitizer for multimodal therapy of deep tumor
Wen et al. On-demand phototoxicity inhibition of sensitizers and H2S-triggered in-situ activation for precise therapy of colon cancer
Yue et al. An alternating irradiation strategy‐driven combination therapy of PDT and RNAi for highly efficient inhibition of tumor growth and metastasis
Xiong et al. Tumor‐Activated Prodrug with Synergistic Anti‐Stemness Chemical and Photodynamic Therapies
Wang et al. A NIR‐II‐emissive organic nanomedicine with biomimetic engineering for high‐contrast targeted bioimaging and multiple phototherapies of pancreatic tumors
Liu et al. Polymeric Phthalocyanine‐Based Nanosensitizers for Enhanced Photodynamic and Sonodynamic Therapies
Yang et al. CD44-mediated tumor homing of hyaluronic acid nanogels for hypoxia-activated photodynamic therapy against tumor
Rivlin et al. Molecular imaging of tumors by chemical exchange saturation transfer MRI of glucose analogs
Li et al. Highly efficient synergistic chemotherapy and magnetic resonance imaging for targeted ovarian cancer therapy using hyaluronic acid‐coated coordination polymer nanoparticles
Wang et al. Photostable Cascade‐Activatable Peptide Self‐Assembly on a cancer cell membrane for high‐performance identification of human bladder cancer